Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Stephanie L. Skala"'
Autor:
Caroline T. Simon, Stephanie L. Skala, Paul D. Killen, Javed Siddiqui, Xuhong Cao, Yuanyuan Qiao, Hikmat Al-Ahmadie, Sandra I. Camelo-Piragua, Jeffrey Jentzen, Arul M. Chinnaiyan, Saravana M. Dhanasekaran, Zachery R. Reichert, Rohit Mehra
Publikováno v:
Diagnostic Pathology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Background Rapid (“warm”) autopsies of patients with advanced metastatic cancer provide important insight into the natural history, pathobiology and histomorphology of disease in treatment-resistant tumors. Plasmacytoid urothelial carcin
Externí odkaz:
https://doaj.org/article/4578d9058286402a830e582b3e70eab9
Autor:
Stephanie L. Skala, Scott R. Owens, Hong Xiao, Kristy A. Bauman, Scott A. Tomlins, Arul M. Chinnaiyan, Lina Shao, Jeffrey M. Jentzen, David Gordon, Rohit Mehra
Publikováno v:
Urology Case Reports, Vol 9, Iss C, Pp 37-40 (2016)
Hepatic cirrhosis is commonly associated with hyperestrogenism. Previous studies have reported morphologic changes in benign and malignant prostate tissue exposed to estrogen or anti-androgens. To our knowledge, histopathologic features of prostatic
Externí odkaz:
https://doaj.org/article/98e33328340e4f358804eb2ca9f6def3
Autor:
Rita A. Avelar, Amy J. Armstrong, Gracie Carvette, Riya Gupta, Noah Puleo, Jose A. Colina, Peronne Joseph, Alexander M. Sobeck, Caitlin M. O'Connor, Brynne Raines, Agharnan Gandhi, Michele L. Dziubinski, Daniel S. Ma, Kimberly Resnick, Sareena Singh, Kristine Zanotti, Christa Nagel, Steven Waggoner, Daffyd G. Thomas, Stephanie L. Skala, Junran Zhang, Goutham Narla, Analisa DiFeo
Publikováno v:
Molecular Cancer Therapeutics. 22:599-615
High-grade serous carcinoma (HGSC) is the most common and lethal ovarian cancer subtype. PARP inhibitors (PARPi) have become the mainstay of HGSC-targeted therapy, given that these tumors are driven by a high degree of genomic instability (GI) and ho
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:499-511
Although papillary renal cell carcinoma has historically been classified as either type 1 or type 2, data from The Cancer Genome Atlas (TCGA) has demonstrated significant genomic heterogeneity in tumors classified as "type 2 papillary renal cell carc
Autor:
Analisa DiFeo, Goutham Narla, Junran Zhang, Stephanie L. Skala, Daffyd G. Thomas, Steven Waggoner, Christa Nagel, Kristine Zanotti, Sareena Singh, Kimberly Resnick, Daniel S. Ma, Michele L. Dziubinski, Agharnan Gandhi, Brynne Raines, Caitlin M. O'Connor, Alexander M. Sobeck, Peronne Joseph, Jose A. Colina, Noah Puleo, Riya Gupta, Gracie Carvette, Amy J. Armstrong, Rita A. Avelar
Fig. S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35fb0df1df4796d0ca534c5991b1c5a9
https://doi.org/10.1158/1535-7163.22758792.v1
https://doi.org/10.1158/1535-7163.22758792.v1
Autor:
Analisa DiFeo, Goutham Narla, Junran Zhang, Stephanie L. Skala, Daffyd G. Thomas, Steven Waggoner, Christa Nagel, Kristine Zanotti, Sareena Singh, Kimberly Resnick, Daniel S. Ma, Michele L. Dziubinski, Agharnan Gandhi, Brynne Raines, Caitlin M. O'Connor, Alexander M. Sobeck, Peronne Joseph, Jose A. Colina, Noah Puleo, Riya Gupta, Gracie Carvette, Amy J. Armstrong, Rita A. Avelar
High-grade serous carcinoma (HGSC) is the most common and lethal ovarian cancer subtype. PARP inhibitors (PARPi) have become the mainstay of HGSC-targeted therapy, given that these tumors are driven by a high degree of genomic instability (GI) and ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26e6f3c08b0a2750fd72bd0b45b54a87
https://doi.org/10.1158/1535-7163.c.6611321.v1
https://doi.org/10.1158/1535-7163.c.6611321.v1
Autor:
Analisa DiFeo, Goutham Narla, Junran Zhang, Stephanie L. Skala, Daffyd G. Thomas, Steven Waggoner, Christa Nagel, Kristine Zanotti, Sareena Singh, Kimberly Resnick, Daniel S. Ma, Michele L. Dziubinski, Agharnan Gandhi, Brynne Raines, Caitlin M. O'Connor, Alexander M. Sobeck, Peronne Joseph, Jose A. Colina, Noah Puleo, Riya Gupta, Gracie Carvette, Amy J. Armstrong, Rita A. Avelar
Table S1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f9225af97666e9514aabae0c355fbbc
https://doi.org/10.1158/1535-7163.22674500.v1
https://doi.org/10.1158/1535-7163.22674500.v1
Autor:
Batoul A. Aoun, Stephanie L. Skala
Publikováno v:
Histopathology. 80:1102-1111
Distinction between well-differentiated endometrial carcinoma (EMCA) with microglandular/mucinous features and benign endocervical microglandular hyperplasia (MGH) can be a diagnostic challenge, especially when tissue is limited. The immunostains use
Publikováno v:
Histopathology. 80:946-953
As gender-affirming surgery is becoming more common, it is important for pathologists to recognize potential benign findings to avoid misinterpretation. Cervical transitional cell metaplasia and superficial clusters of small basophilic cells have bee
Publikováno v:
Archives of Pathology & Laboratory Medicine.
Context.— Differentiated vulvar intraepithelial neoplasia (dVIN) is a human papillomavirus–independent lesion with the potential for rapid progression to invasive squamous cell carcinoma (SCC). The histopathologic features of dVIN are diverse, ha